Abstract
Introduction

Pre-eclampsia is a multi-system disorder that is unique to human pregnancy, affecting 5-7% of pregnancies worldwide. The clinical features of pre-eclampsia can manifest as either a maternal syndrome (hypertension and proteinuria with or without other multi-system dysfunction occurring during the third trimester of pregnancy) or foetal syndrome (foetal growth restriction, perinatal deaths, preterm birth and abnormal oxygenation). Although the aetiology of pre-eclampsia is largely unknown, the placenta in general and trophoblast in particular is a prerequisite for the development of the disease [1, 2]. It is characterized by incomplete trophoblast invasion and aberranted spiral arterial remodelling leading to decreased uteroplacental perfusion and, therefore, is thought to give rise to placental ischaemia and hypoxia. This theory has been further strengthened by clinical observations that in women destined to develop pre-eclampsia, uteroplacental blood flow is reduced by 50-70%
. In some studies, the hypoxia-inducible factor (HIF) protein levels are significantly elevated in the pre-eclamptic placenta [5, 6] . Furthermore, restriction of placental perfusion in several animal species has resulted in a pre-eclampsia-like illness [7] , and experimental hypoxia is also correlated with pre-eclampsia features [8] . These [11] , but the functions of specific miRNA molecules are still being determined. Over the past 3 years, several independent studies have reported that some specific miRNAs are highly up- [12] [13] [14] [15] [16, 17] . However, the underlying mechanism was not elucidated. 
regulated in hypoxic cells and demonstrated their importance for cell response to hypoxia. Screening to identify hypoxia-induced miRNAs has initially focused on culturing a variety of tumour cells under hypoxic conditions, given that hypoxia is a typical characteristic of solid tumours
In this study, we investigated whether mir-210 contributes to the pathogenesis of pre-eclampsia, a complex disorder widely believed to be associated with placental hypoxia. Our results show that mir-210 is induced in patients with pre-eclampsia and in hypoxia-treated trophoblast cells. The up-regulated mir-210 attenuates trophoblast cell migration and invasion by repressing expression of Homeobox-A9 (HOXA9) and Ephrin-A3 (EFNA3
Materials and methods
Patient enrollment and sample processing
Isolation and culture of cytotrophoblast cells, culture of JAR cells and cell treatments
The procedures to isolated cytotrophoblast cells (CT) were performed as described previously [20] . Briefly, the first trimester placenta tissues (5- Table S2 . 
Plasmid constructs and luciferase activity assays
Transwell migration and matrigel invasion assay
Cell migration and invasion assays were performed as described previously [22] . Cells ( 
Results
Plasma mir-210 level is increased in patients with pre-eclampsia
The expression level of mir-210 is dramatically increased in placental tissues from patients with pre-eclampsia [16, 17] (Fig. 3A and B) and invasion ( Fig. 3C and D) capacity. To demonstrate whether mir-210 involved in the suppressed invasion capability is elicited by hypoxia, CT cells were then exposed to 72 hrs of hypoxia. As expected, hypoxia treatment inhibited cell migration (Fig. 3A and B) and invasion ( Fig. 3C and D) , yielding a similar result to that observed in cells overexpressing mir-210 (Fig. 3) [25] , whereas the homeoboxs encoding for transcription factors are responsible for biological functions, also including cell migration and vascular development [26] . These two targeted candidates, therefore, attracted our interest. As shown in Figure S1A Figure S1C and (Fig. S1E) , © 
and B, the EFNA3 or HOXA9-encoded mRNA contains a 3Ј-UTR element that is partially complementary to mir-210, indicating that mir-210 would directly target these sites. To validate this prediction, the EFNA3 or HOXA9 complementary sites were cloned into the 3Ј-UTR of the firefly luciferase vector and cotransfected with mir-210 mimics or negative controls in JAR cells. As shown in
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Fig. 3 Determination of mir-210 involvement in trophoblast cell migration and invasion by transwell assays. Representative migration (A) or invasion (C) experiment of CT cells transfected with mir-210 mimics (under normoxic conditions), anti-mir-210 (under hypoxic conditions) or negative controls. Size bar ϭ 50 m. The percentage of migrated cells (B) or invaded cells (D) is shown as means and standard deviations based on at least three independent experiments. **P Ͻ 0.001. whereas the reduction of HOXA9 was observed at both the mRNA and protein levels in comparison with negative controls in JAR cells (Fig. S1F). Above results strongly indicate that with mir-210, EFNA3 expression is suppressed by translational repression whereas HOXA9 expression is suppressed by both mRNA degradation and translational repression.
Ephrin-A3 and homeobox-A9 expression are down-regulated in placentas from patients with pre-eclampsia
The up-regulation expression of mir-210 in placental tissues from patients with pre-eclampsia has been shown [16, 17] (Fig. 4B) . The EFNA3 expression in placental tissues was similar to that observed above for JAR cells, that is, EFNA3 mRNA levels were not significantly affected, whereas protein levels decreased substantially (Fig. 4A) .
mir-210 is regulated by the transcription factor NF-B p50
Since the hypoxia regulation of mir-210 was first identified by miRNA microarray in 2007 [15] , several studies have reported that mir-210 was regulated by HIF 1␣ [12, 14, 27] or HIF 2␣ [28] . Indeed, HIF is central to the cellular response to hypoxia, but it is not alone in displaying sensitivity to oxygen levels. There are several other transcription factors have been reported to display hypoxia sensitivity [29] , principal among which is the transcription factor NF-B. In contrast to HIF being activated by hypoxia, NF-B has been long considered to be activated by oxidative stress, recent study provided evidence that both transcription factors are responsive to both conditions [30] . More importantly, NF-B transcriptional activity was found significantly enhanced in patients with pre-eclampsia [31] [32] [33] (Fig. 5A) , which was consistent with the variation of mir-210 in the same conditions. (Fig. 5B) [14] . In this study, we search the potential mir-210 regulator in a 200-bp core promoter region immediately upstream of mir-210 stem-loop structure. Serial deletion constructs were made and reporter assays were performed to determine the effect of the deletions on reporter gene activity (Fig. 5C) [34] and found that NF-B subunit p50 localizes within this promoter region (Fig. 5D) 
. In our experimental set-up, NF-B p50 transcriptional activity dramatically increased when JAR cells cultured under hypoxic conditions
Furthermore, JAR cells treated with the tumour-necrosis factor (TNF), a commonly used activator of NF-B, resulting in significantly increased mir-210 levels
256
An about 1 kb promoter sequence upstream of mir-210 stemloop structure that includes HIF1␣ and p50 response elements was cloned into the pGL3-Basic vector to assessed whether the luciferase activity was induced by both of the two elements. The HIF 1␣-and p50-binding sites were then mutated and the transcriptional activities of the mutated promoters were determined. As shown in Figure 5D , independent mutation of the HIF 1␣-or p50-binding [35, 36] . This suggests that other factors are also likely to affect the occurrence and expression of the disease.
The discovery of nucleic acids circulating in the peripheral blood has created a new approach for the non-invasive diagnosis of clinical diseases [37, 38] . Circulating mRNA molecules have been investigated as potential markers for disease, and recent studies on miRNAs offer the possibility of developing yet another class of molecular markers [19, 39] [14, 43, 44] . EFNA3 is a member of the ephrin ligand family, which function during the development of diverse organ systems including axon guidance and cell migration [25] [26] . We reported here that a significant down-modulation of HOXA9, both at mRNA and protein levels appeared in pre-eclampsia placentas compared to healthy control tissues, which is consistent with the role of HOXA9 reported in the previous study [26] .
Because of the critical role of the HIF in hypoxic response, so far almost all studies about the signaling pathway involved in mir-210 regulation are performed around the HIF transcription factor [12, 14, 27, 28] . However, it is clear that a number of other transcription factors are also activated by hypoxia either directly or indirectly, such as activator protein-1, NF-B and CREB [29] . Interestingly, NF-B p50 transcriptional activity could be significantly induced in patient with pre-eclampsia [31] [32] [33] [46] , and in basal levels of HIF 1␣ gene expression [47, 48] . More importantly, the above found has been proved to occur in vivo [47] . The HIF 1␣ promoter contains a canonical NF-B-binding site at a position-197/-188 upstream of the transcriptional start site, the mutation of which leads to a loss of HIF 1␣ up-regulation by hypoxia [47, 48] 
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